Covid-19 has shaken world markets. One question likely to be on the minds of a lot of investors right now is how economic uncertainty caused by the pandemic will continue to affect small-cap shares, such as the share price of Bioventix (LON:BVXP).
Shares in Bioventix are currently trading at 4117. But to assess whether the price is likely to fall or rally over the next 12 months, we need an objective way of telling whether the company is able to withstand economic shocks and ride out market volatility. To do that, it’s essential to look at the profile of the stock to see where its strengths are.
Importantly, we’re interested in finding impartial ways of looking at Bioventix – something that takes emotion out of the analysis…
The good news is that it scores well against some important financial and technical measures. In particular, it shows signs of being a high quality, strong momentum stock.
Research shows that high quality stocks tend to be resilient, cash-generating businesses that can compound investment returns over time. Likewise, strong momentum in price and earnings is a pointer to positive trends that have the potential to continue.